TENIPOSIDE IN SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP

被引：0
|
作者：
MUSS, HB
BUNDY, BN
YAZIGI, R
YORDAN, E
机构：
[1] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,WINSTON SALEM,NC 27103
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GYNECOL ONCOL GRP,BUFFALO,NY 14263
[3] UNIV TEXAS,HLTH SCI CTR,SW MED SCH,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,DALLAS,TX 75235
[4] RUSH PRESBYTERIAN ST LUKES MED CTR,GYNECOL ONCOL SECT,CHICAGO,IL 60612
来源：
CANCER TREATMENT REPORTS | 1987年 / 71卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：873 / 874
页数：2
相关论文
共 50 条
  • [21] CIS-PLATINUM IN TREATMENT OF ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A PHASE-II STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP
    THIGPEN, T
    SHINGLETON, H
    HOMESLEY, H
    LAGASSE, L
    BLESSING, J
    CANCER, 1981, 48 (04) : 899 - 903
  • [22] A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study
    Steven C. Plaxe
    John A. Blessing
    George Olt
    Nader Husseinzadah
    Samuel S. Lentz
    Koen DeGeest
    Fidel A. Valea
    Cancer Chemotherapy and Pharmacology, 2002, 50 : 151 - 154
  • [23] A Phase II Trial of Erlotinib in Recurrent Squamous Cell Carcinoma of the Cervix A Gynecologic Oncology Group Study
    Schilder, Russell J.
    Sill, Michael W.
    Lee, Yi-Chun
    Mannel, Robert
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (05) : 929 - 933
  • [24] Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix - A gynecologic oncology group study
    Lincoln, S
    Blessing, JA
    McGehee, R
    Lentz, SS
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (01): : 84 - 85
  • [25] A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study
    Plaxe, SC
    Blessing, JA
    Olt, G
    Husseinzadah, N
    Lentz, SS
    DeGeest, K
    Valea, FA
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (02) : 151 - 154
  • [26] 5-FLUOROURACIL AND LOW-DOSE LEUCOVORIN IN THE TREATMENT OF RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A PHASE-II TRIAL OF THE GYNECOLOGIC-ONCOLOGY-GROUP
    LOOK, KY
    BLESSING, JA
    MUSS, HB
    PARTRIDGE, EE
    MALFETANO, JH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (06): : 497 - 499
  • [27] PHASE-II TRIAL OF VP-16-213 IN THE TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX AND ADENOCARCINOMA OF THE OVARY - GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAYTON, RE
    CREASMAN, WT
    PETTY, W
    BUNDY, B
    BLESSING, JA
    CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 2089 - 2092
  • [28] A PHASE-II EVALUATION OF CISPLATIN AND 5-FLUOROURACIL IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    BONOMI, P
    BLESSING, J
    BALL, H
    HANJANI, P
    DISAIA, PJ
    GYNECOLOGIC ONCOLOGY, 1989, 34 (03) : 357 - 359
  • [29] A PHASE-II STUDY OF FAZARABINE (NSC-281272) IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    MANETTA, A
    BLESSING, JA
    MANN, WJ
    SMITH, DM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (05): : 439 - 440
  • [30] Topotecan in squamous cell carcinoma of the cervix: A phase II study of the gynecologic oncology group
    Bookman, MA
    Blessing, JA
    Hanjani, P
    Herzog, TJ
    Andersen, WA
    GYNECOLOGIC ONCOLOGY, 2000, 77 (03) : 446 - 449
12345